Home › Funds › EcoR1 Capital, LLC › ORIC

EcoR1 Capital, LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

EcoR1 Capital, LLC reported holding 3,028,116 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$40.8M, representing 1.93% of its reported portfolio and ranking #11 among its reported holdings. EcoR1 Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.03M sh
Reported value held$40.79M
Portfolio Weight1.93%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's ORIC position evolved

EcoR1 Capital, LLC first disclosed a stake in ORIC in Q3 2023 at 3,418,068 shares (US$20.7M). The position peaked in Q1 2026 at 6,728,116 shares, worth US$85.2M. Across 13 filings, EcoR1 Capital, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 3,028,116 shares valued at US$40.8M — a reduction of -3,700,000 shares quarter over quarter.. Notable position changes include a 53% trim in Q2 2025 (shares rose 18% over the following quarter), a 316% increase in Q3 2025 (shares fell 32% over the following quarter), a 55% trim in Q3 2026 (shares fell 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.42M $20.68M New
Q4 2023 3.42M $31.45M Hold
Q1 2024 3.42M $47.00M Hold
Q2 2024 3.42M $24.17M Hold
Q3 2024 3.42M $35.04M Hold
Q4 2024 3.42M $27.58M Hold
Q1 2025 3.42M $19.07M Hold
Q2 2025 1.62M $16.42M Reduce
Q3 2025 6.73M $80.74M Add
Q4 2025 6.73M $55.04M Hold
Q1 2026 6.73M $85.25M Hold
Q2 2026 6.73M $72.87M Hold
Q3 2026 3.03M $40.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has EcoR1 Capital, LLC held ORIC?

EcoR1 Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EcoR1 Capital, LLC's current position in ORIC?

As of Q3 2026, EcoR1 Capital, LLC holds 3.03M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $40.79M, representing 1.93% of its reported portfolio and ranking #11.

Has EcoR1 Capital, LLC been buying or selling ORIC?

In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC reduced its position in ORIC. The position peaked in Q1 2026 at 6.73M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.